Published on
05:41 GMT
FDA After the Storm: Drug Review Delays and Increased Executive Oversight Expected
Hordes of HHS employees, including 3,500 FDA staffers and more than half of its senior leadership, are gone, prompting former FDA Commissioner Robert Califf to write on LinkedIn last week: “The FDA as we’ve known it is finished.” This, of course, begs the …
Source:
BioSpace
-
Label Pending
